Effect of anti-iduronidase sulfatase in patients with Mucopolysaccharidosis type II treated with enzyme replacement therapy.
Vollebregt AAM, Hoogeveen-Westerveld M, Ruijter GJ, van den Hout H, Oussoren E, van der Ploeg AT, Pijnappel WWMP
The Journal of pediatrics, 2022 May 11
Abstract
To assess the relationship between anti-Iduronidase sulfatase (IDS), IDS genotypes, phenotypes and their impact in enzyme replacement therapy (ERT)-treated Mucopolysaccharidosis type II patients.